Development of a New Tool to Assess Bolus Calculation and Carbohydrate Estimation

Diabetes Technology & Therapeutics
Dominic EhrmannBernhard Kulzer

Abstract

Carbohydrate estimation and bolus calculation are two important skills for handling intensive insulin therapy and effectively using bolus calculators. Structured assessment of both skills is lacking. A new tool for the assessment of skills in carbohydrate estimation and bolus calculation was developed and evaluated. A new assessment tool (SMART) was developed that included 10 items for bolus calculation and 12 items for carbohydrate estimation. In total, 411 patients on intensive insulin treatment were recruited. Different parameters of glycemic control were used as validity criteria. The SMART tool achieved good reliability for the assessment of bolus calculation (Cronbach's α = 0.78) and sufficient reliability for the assessment of carbohydrate estimation (Cronbach's α = 0.67). A good bolus calculation skill was significantly associated with lower glycated hemoglobin values (r = -0.27), lower mean blood glucose levels (r = -0.29), and higher fluctuation of blood glucose control (r = -0.43). A good carbohydrate estimation skill was significantly associated with a lower frequency of severe hyperglycemia (r = -0.27) and a higher frequency of euglycemia (r = 0.26). SMART is a reliable and valid tool for the assessment of both ski...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Dec 24, 2005·The New England Journal of Medicine·David M NathanUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research
Mar 19, 2008·Journal of Pediatric Psychology·Tim WysockiUNKNOWN Family Management of Childhood Diabetes Steering Committee
May 3, 2008·BMC Health Services Research·Mary Margaret HuizingaRussell L Rothman
Aug 22, 2008·Diabetes Technology & Therapeutics·Satish K GargPeter A Gottlieb
Oct 24, 2009·The New England Journal of Medicine·Rury R HolmanUNKNOWN 4-T Study Group
Jun 12, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·C E SmartC E Collins
Oct 7, 2010·Journal of Diabetes·Aila J AholaUNKNOWN FinnDIANE Study Group
Dec 7, 2010·Journal of Diabetes Science and Technology·David Kerr
Dec 7, 2010·Journal of Diabetes Science and Technology·David KerrUNKNOWN study investigators
Mar 2, 2011·Diabetes Technology & Therapeutics·Anna Rita MauriziPaolo Pozzilli
Jun 8, 2012·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·G LeporeR Trevisan
Mar 14, 2014·The Lancet. Diabetes & Endocrinology·Kirstine J BellJennie C Brand-Miller
Mar 25, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·S SchmidtK Nørgaard

❮ Previous
Next ❯

Citations

Mar 31, 2016·Diabetes Technology & Therapeutics·Vikash Dadlani, Yogish C Kudva
Aug 25, 2020·Diabetes Technology & Therapeutics·Melanie B GillinghamCorby K Martin

❮ Previous
Next ❯

Software Mentioned

BOLUS
PedCarbQuiz
CARB
SYSTAT
- CARB
SMART
- BOLUS

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.